CN107156805A - 一种保健品及其制造方法 - Google Patents
一种保健品及其制造方法 Download PDFInfo
- Publication number
- CN107156805A CN107156805A CN201710036493.8A CN201710036493A CN107156805A CN 107156805 A CN107156805 A CN 107156805A CN 201710036493 A CN201710036493 A CN 201710036493A CN 107156805 A CN107156805 A CN 107156805A
- Authority
- CN
- China
- Prior art keywords
- health products
- catsup
- powder
- raw material
- following parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title claims abstract description 33
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 13
- 238000000034 method Methods 0.000 title claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 33
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 21
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 18
- 235000012907 honey Nutrition 0.000 claims abstract description 16
- 235000011837 pasties Nutrition 0.000 claims abstract description 4
- 244000045195 Cicer arietinum Species 0.000 claims description 18
- 235000010523 Cicer arietinum Nutrition 0.000 claims description 18
- 235000013372 meat Nutrition 0.000 claims description 17
- 235000017643 Elaeagnus angustifolia Nutrition 0.000 claims description 16
- 244000016119 Elaeagnus latifolia Species 0.000 claims description 16
- 235000001456 Elaeagnus latifolia Nutrition 0.000 claims description 16
- 235000007630 Elaeagnus umbellata var parvifolia Nutrition 0.000 claims description 16
- 235000009496 Juglans regia Nutrition 0.000 claims description 14
- 235000020234 walnut Nutrition 0.000 claims description 14
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 10
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 10
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 10
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 10
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 10
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 10
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 10
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 10
- 240000000171 Crataegus monogyna Species 0.000 claims description 10
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 10
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 10
- 240000007164 Salvia officinalis Species 0.000 claims description 10
- 235000005412 red sage Nutrition 0.000 claims description 10
- 244000078118 Ilex latifolia Species 0.000 claims description 9
- 235000008706 Ilex latifolia Nutrition 0.000 claims description 9
- 244000126002 Ziziphus vulgaris Species 0.000 claims description 8
- 240000002924 Platycladus orientalis Species 0.000 claims description 7
- 240000000950 Hippophae rhamnoides Species 0.000 claims description 5
- 240000007049 Juglans regia Species 0.000 claims 3
- 244000144730 Amygdalus persica Species 0.000 claims 1
- 235000006040 Prunus persica var persica Nutrition 0.000 claims 1
- 241000229143 Hippophae Species 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 14
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 9
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 5
- 239000011707 mineral Substances 0.000 abstract description 5
- 235000010755 mineral Nutrition 0.000 abstract description 5
- 235000007688 Lycopersicon esculentum Nutrition 0.000 abstract description 4
- 235000012000 cholesterol Nutrition 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 229930003231 vitamin Natural products 0.000 abstract description 4
- 235000013343 vitamin Nutrition 0.000 abstract description 4
- 239000011782 vitamin Substances 0.000 abstract description 4
- 229940088594 vitamin Drugs 0.000 abstract description 4
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 4
- 206010002383 Angina Pectoris Diseases 0.000 abstract description 3
- 102000040350 B family Human genes 0.000 abstract description 3
- 108091072128 B family Proteins 0.000 abstract description 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 abstract description 3
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 abstract description 3
- 230000003143 atherosclerotic effect Effects 0.000 abstract description 3
- 230000000975 bioactive effect Effects 0.000 abstract description 3
- 235000013325 dietary fiber Nutrition 0.000 abstract description 3
- 208000019622 heart disease Diseases 0.000 abstract description 3
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 abstract description 3
- 235000012661 lycopene Nutrition 0.000 abstract description 3
- 229960004999 lycopene Drugs 0.000 abstract description 3
- 239000001751 lycopene Substances 0.000 abstract description 3
- 239000001814 pectin Substances 0.000 abstract description 3
- 235000010987 pectin Nutrition 0.000 abstract description 3
- 229920001277 pectin Polymers 0.000 abstract description 3
- 102000004169 proteins and genes Human genes 0.000 abstract description 3
- 108090000623 proteins and genes Proteins 0.000 abstract description 3
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 2
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 241000227653 Lycopersicon Species 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 1
- 241001247821 Ziziphus Species 0.000 description 14
- 241000758789 Juglans Species 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 230000009467 reduction Effects 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 4
- 241000218691 Cupressaceae Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000002929 anti-fatigue Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000001603 reducing effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 208000002249 Diabetes Complications Diseases 0.000 description 2
- 206010012655 Diabetic complications Diseases 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000000496 cardiotonic agent Substances 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 210000002221 olecranon process Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000004611 cancer cell death Effects 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000005186 women's health Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明提供一种保健品及其制造方法,其中所述保健品包括以下重量份的原材料:番茄酱25‑35;黑蜂蜜20‑30;沙棘粉20‑30。制备方法包括:将沙棘粉过100目筛后,与番茄酱、黑蜂蜜充分混合并调成糊状。本发明实施例提出的保健品,其中黑蜂蜜具有清热的功效;番茄酱富含番茄红素、B族维生素、膳食纤维、矿物质、蛋白质、天然果胶,比新鲜番茄更易被人体吸收;沙棘等,和新鲜番茄相比较,番茄酱里的营养成分更容易被人体吸收;沙棘果实制成的沙棘粉含有丰富的营养物质和生物活性物质,可降低胆固醇,缓解心绞痛发作,防治冠状动脉粥样硬化性心脏病。
Description
技术领域
本发明涉及保健品技术领域,尤其是指一种保健品及其制造方法。
背景技术
随着社会的不断发展,人们越来越注重保健养生。很多绿色保健品标榜自己采用纯天然原料制造,但是在制造过程中不可避免会包括很多化学提纯工序,而这些工序必然导致最终产品并不是绿色纯天然的。
发明内容
针对现有技术中存在的保健品需要多次加工导致最终产品并非绿色纯天然的问题,本发明要解决的技术问题是提出一种保健品及其制造方法,能够在保持原材料天然性的基础上同时具有很好的保健效果。
为了解决上述问题,本发明实施例提出了一种保健品,包括以下重量份的原材料:番茄酱25-35;黑蜂蜜20-30;沙棘粉20-30。
其中,还可以包括以下重量份的原材料:枣肉5-10;核桃粉5-10;鹰嘴豆5-10;沙枣5-10;葡萄籽油5-10。
其中,还包括以下重量份的原材料:苦丁茶1-2;丹参1-2;山楂4-6;酸枣仁5-6;柏子仁5-6;天麻1-2。
其中,所述保健品由以下重量份的原材料制成:番茄酱30、黑蜂蜜25、沙棘粉25、枣肉5、核桃粉5、鹰嘴豆5、沙枣5、葡萄籽油5。
其中,所述保健品由以下重量份的原材料制成:番茄酱30、黑蜂蜜25、沙棘粉25、枣肉5、核桃粉5、鹰嘴豆5、沙枣5、葡萄籽油5、苦丁茶2、丹参2、山楂5、酸枣仁5、柏子仁5、天麻2。
同时,本发明实施例还提出了一种如前任一项所述的保健品的制造方法,包括:
同时,本发明实施例还提出了一种如前任一项所述的保健品的制造方法,包括:
将枣肉、鹰嘴豆、沙枣、苦丁茶、丹参、山楂、酸枣仁、柏子仁、天麻粉碎后过100目筛,
在对沙棘粉、番茄酱、黑蜂蜜混合并搅拌时,同时加入枣肉、鹰嘴豆、沙枣的粉末以及核桃粉、葡萄籽油,充分混合并调成糊状。
本发明的上述技术方案的有益效果如下:上述技术方案提出了一种保健品及其制造方法,其中黑蜂蜜具有清热的功效;番茄酱富含番茄红素、B族维生素、膳食纤维、矿物质、蛋白质、天然果胶,比新鲜番茄更易被人体吸收;沙棘果实制成的沙棘粉含有丰富的营养物质和生物活性物质,可降低胆固醇,缓解心绞痛发作,防治冠状动脉粥样硬化性心脏病。苦丁茶具有清热消暑、明目益智、生津止渴、利尿强心、润喉止咳、降压减肥、抑癌防癌、抗衰老、活血脉等多种功效。丹参具有活血祛瘀,通经止痛,清心除烦,凉血消痈之功效。山楂具有降血脂、血压、强心、抗心律不齐等作用。酸枣仁具有补中益肝,坚筋骨,助阴气的功效。柏子仁具有养心安神,润肠通便,止汗的功效。天麻具有平肝息风止痉的功效。
本发明实施例提出的保健品,具有清热、抗疲劳、减脂的效果。在为期三个月、包括318白领的试用人群进行试用时,服用者自述在服用保健品后明显感觉的抗疲劳降低,血脂略有降低。
具体实施方式
为使本发明要解决的技术问题、技术方案和优点更加清楚,下面以具体的实例对本发明进行进一步说明。
本发明实施例提出了一种保健品,包括以下重量份的原材料:番茄酱25-35;黑蜂蜜20-30;沙棘粉20-30。
其中,还可以包括以下重量份的原材料:枣肉5-10;核桃粉5-10;鹰嘴豆5-10;沙枣5-10;葡萄籽油5-10。
其中,还包括以下重量份的原材料:苦丁茶1-2;丹参1-2;山楂4-6;酸枣仁5-6;柏子仁5-6;天麻1-2。
其中,所述保健品由以下重量份的原材料制成:番茄酱30、黑蜂蜜25、沙棘粉25、枣肉5、核桃粉5、鹰嘴豆5、沙枣5、葡萄籽油5。
其中,所述保健品由以下重量份的原材料制成:番茄酱30、黑蜂蜜25、沙棘粉25、枣肉5、核桃粉5、鹰嘴豆5、沙枣5、葡萄籽油5、苦丁茶2、丹参2、山楂5、酸枣仁5、柏子仁5、天麻2。
同时,本发明实施例还提出了一种如前任一项所述的保健品的制造方法,包括:
同时,本发明实施例还提出了一种如前任一项所述的保健品的制造方法,包括:
将枣肉、鹰嘴豆、沙枣、苦丁茶、丹参、山楂、酸枣仁、柏子仁、天麻粉碎后过100目筛,
在对沙棘粉、番茄酱、黑蜂蜜混合并搅拌时,同时加入枣肉、鹰嘴豆、沙枣的粉末以及核桃粉、葡萄籽油,充分混合并调成糊状。
在本发明的上述实施例中,番茄酱可以采用市场上销售的任何纯番茄酱;枣肉则为含水量不高于10%的干枣的枣肉;核桃粉可以为薄皮核桃的核桃仁磨制而成。
其中黑蜂蜜具有清热的功效。
番茄酱富含番茄红素、B族维生素、膳食纤维、矿物质、蛋白质、天然果胶,比新鲜番茄更易被人体吸收;沙棘等,和新鲜番茄相比较,番茄酱里的营养成分更容易被人体吸收。
沙棘果实制成的沙棘粉含有丰富的营养物质和生物活性物质,可降低胆固醇,缓解心绞痛发作,防治冠状动脉粥样硬化性心脏病。
鹰嘴豆异黄酮对女性健康的影响很大,是具有活性的植物性类雌激素,它能够延迟女性细胞衰老,使皮肤保持弹性、养颜、丰乳、减少骨质丢失,促成骨生成、降血脂、减轻女性更年期综合症状等。鹰嘴豆异黄酮也有防止癌细胞的增殖,促使癌细胞死亡的作用。鹰嘴豆对糖尿病具有控制、降低血糖,预防和减缓糖尿病并发症的作用。鹰嘴豆中含有的铬元素和多不饱和脂肪酸可促进胆固醇代谢防止脂质在肝脏和动脉壁沉积、降低血小板凝结能力,防止血栓形成。防止血管损伤面的炎症反应,对血管有良好的保护作用,可有效的预防和减缓糖尿病并发症。很多血糖高居不下,波动较大,不稳定的糖尿病患者,在食用了鹰嘴豆产品3个月之内血糖都得到了有效的控制,其并发症也得到了有效的预防和减缓。
干枣富含矿物质,对防癌和预防高血压、高血脂都有一定作用。据《黄帝内经》《本草纲目》[记载:枣具有益气养肾、补血养颜、补肝降压、安神壮阳、治虚劳损之功效。红枣中含量丰富的环磷酸腺苷、儿茶酸具有独特的防癌降压功效,故枣是极佳的营养滋补品。其功效为:健脾益胃。
沙枣具有养肝益肾,健脾调经之功效;常用于肝虚目眩,肾虚腰痛,脾虚腹泻,消化不良,带下,月经不调。
葡萄籽油葡萄籽油含有丰富的不饱和脂肪酸,主要是油酸和亚油酸,其中亚油酸的含量高达72%~76%。亚油酸是人体必需脂肪酸,易于被人体吸收,长期食用葡萄籽油可降低人体血清胆固醇,有效调节人的植物神经功能。葡萄籽油富含维生素E,具有较强的抗氧化性,能够有效地延长货架保质期,不易引起由于光照、热辐射和与空气接触而产生的氧化酸败现象。葡萄籽油中还含有人体必需的钾、钠、钙等矿物质及各种脂溶性及水溶性维生素。
在为期三个月、包括318白领的试用人群进行试用时,服用者自述在服用保健品后明显感觉的抗疲劳降低,血脂略有降低。
以上所述是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明所述原理的前提下,还可以作出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。
Claims (6)
1.一种保健品,其特征在于,包括以下重量份的原材料:番茄酱25-35;黑蜂蜜20-30;沙棘粉20-30。
2.根据权利要求1所述的保健品,其特征在于,还包括以下重量份的原材料:枣肉5-10;核桃粉5-10;鹰嘴豆5-10;沙枣5-10;葡萄籽油5-10。
3.根据权利要求2所述的保健品,其特征在于,还包括以下重量份的原材料:苦丁茶1-2;丹参1-2;山楂4-6;酸枣仁5-6;柏子仁5-6;天麻1-2。
4.根据权利要求2所述的保健品,其特征在于,所述保健品由以下重量份的原材料制成:番茄酱30、黑蜂蜜25、沙棘粉25、枣肉5、核桃粉5、鹰嘴豆5、沙枣5、葡萄籽油5。
5.根据权利要求3所述的保健品,其特征在于,所述保健品由以下重量份的原材料制成:番茄酱30、黑蜂蜜25、沙棘粉25、枣肉5、核桃粉5、鹰嘴豆5、沙枣5、葡萄籽油5、苦丁茶2、丹参2、山楂5、酸枣仁5、柏子仁5、天麻2。
6.一种权利要求1-5任一项所述的保健品的制造方法,其特征在于,包括:
将枣肉、鹰嘴豆、沙枣、苦丁茶、丹参、山楂、酸枣仁、柏子仁、天麻粉碎后过100目筛,
在对沙棘粉、番茄酱、黑蜂蜜混合并搅拌时,同时加入枣肉、鹰嘴豆、沙枣的粉末以及核桃粉、葡萄籽油,充分混合并调成糊状。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710036493.8A CN107156805A (zh) | 2017-01-18 | 2017-01-18 | 一种保健品及其制造方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710036493.8A CN107156805A (zh) | 2017-01-18 | 2017-01-18 | 一种保健品及其制造方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107156805A true CN107156805A (zh) | 2017-09-15 |
Family
ID=59849376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710036493.8A Pending CN107156805A (zh) | 2017-01-18 | 2017-01-18 | 一种保健品及其制造方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107156805A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107961293A (zh) * | 2017-11-24 | 2018-04-27 | 王智森 | 一种沙棘番茄片及其制备方法 |
CN115024472A (zh) * | 2022-06-28 | 2022-09-09 | 泸水市天运农业有限公司 | 一种含有米团花蜂蜜保健品配方及生产方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104738777A (zh) * | 2015-03-06 | 2015-07-01 | 东莞市永益食品有限公司 | 一种蜂蜜枸杞番茄汁及其制备方法 |
CN105166887A (zh) * | 2015-08-14 | 2015-12-23 | 湖北坤艳药业有限责任公司 | 一种保健品辅料及其应用 |
-
2017
- 2017-01-18 CN CN201710036493.8A patent/CN107156805A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104738777A (zh) * | 2015-03-06 | 2015-07-01 | 东莞市永益食品有限公司 | 一种蜂蜜枸杞番茄汁及其制备方法 |
CN105166887A (zh) * | 2015-08-14 | 2015-12-23 | 湖北坤艳药业有限责任公司 | 一种保健品辅料及其应用 |
Non-Patent Citations (3)
Title |
---|
李淑芳: "《特种植物油脂加工实用新技术》", 31 March 2010, 天津科技翻译出版社 * |
王绪前: "《中医食疗》", 31 October 2015, 中国中医药出版社 * |
老昌辉: "《食疗与健康》", 31 May 2014, 中国中医药出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107961293A (zh) * | 2017-11-24 | 2018-04-27 | 王智森 | 一种沙棘番茄片及其制备方法 |
CN115024472A (zh) * | 2022-06-28 | 2022-09-09 | 泸水市天运农业有限公司 | 一种含有米团花蜂蜜保健品配方及生产方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108522969A (zh) | 一种可降血糖的复方营养粉剂 | |
CN103610182A (zh) | 一种预防脂肪肝的天然饮料及生产工艺 | |
CN107156805A (zh) | 一种保健品及其制造方法 | |
CN106234920A (zh) | 一种杂粮面粉 | |
CN103609701A (zh) | 一种适合脂肪肝患者饮用的酸奶及加工工艺 | |
CN104513776A (zh) | 一种火龙果果醋的制备方法 | |
CN101991110B (zh) | 野生灵芝系列食品 | |
CN104431434A (zh) | 一种豆渣发酵配方鸡饲料及其制备方法 | |
CN106070808A (zh) | 一种复合饮料及制作方法 | |
CN106234636A (zh) | 一种补血玉米油 | |
CN103461817B (zh) | 一种含木鱼石粉的营养馒头 | |
CN102511882A (zh) | 一种有助于改善生长发育的红枣浓浆 | |
CN101791016B (zh) | 一种养生食用油及其制备方法 | |
CN107125281A (zh) | 一种蛹虫草月饼及其制备方法 | |
CN105767736A (zh) | 一种黑豆猪蹄的制备方法 | |
Arya | Food is your Medicine | |
CN103989073A (zh) | 一种莲藕保健面条及其制备方法 | |
CN103393010A (zh) | 一种山药鸡蓉粥及其制备方法 | |
CN109170391A (zh) | 一种排毒葡萄汁 | |
CN101496569A (zh) | 一种营养保健长寿萝卜菜及其生产加工方法 | |
CN106342982A (zh) | 一种缓解前列腺初期肿胀的黑米糕 | |
CN106551312A (zh) | 一种中老年益寿糕 | |
CN103734629A (zh) | 具有补充蔬菜维生素的功能食品及其制备方法 | |
CN103610152A (zh) | 一种缓解神经衰弱的营养煲汤及其生产制作方法 | |
CN107455759A (zh) | 一种海参营养保健粥 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170915 |